Equine Peptide Therapy: FDA Rules for Horse Treatment

Medically reviewed by Dr. Sarah Chen, PharmD, BCPS

Explore the world of equine peptide therapy and understand the FDA's regulations for horse treatments. Learn about the benefits, risks, and legalities of using peptides.

The Frontier of Equine Medicine: A Guide to Peptide Therapy and FDA Oversight

The world of equine medicine is constantly evolving, with new therapies emerging to enhance the health, performance, and recovery of horses. Among the most promising advancements is peptide therapy. However, as with any new treatment, it's crucial to understand the regulatory landscape. This article provides a comprehensive overview of equine peptide therapy, FDA rules, and what horse owners need to know.

Peptides are short chains of amino acids, the building blocks of proteins. They act as signaling molecules within the body, regulating a vast array of physiological functions, from hormone production to tissue repair. In horses, peptide therapy is being explored for its potential to accelerate healing, reduce inflammation, and improve overall well-being. But are these treatments approved, and what does the U.S. Food and Drug Administration (FDA) say about them?

Understanding the FDA's Role in Veterinary Medicine

The FDA's Center for Veterinary Medicine (CVM) is responsible for ensuring the safety and effectiveness of animal drugs. Before a new drug can be marketed and sold, it must go through a rigorous approval process. This process involves extensive testing to demonstrate that the drug is safe for the animal, the people administering it, and the environment, and that it is effective for its intended use. For more information on the FDA's role, you can visit their page on Animal Drug Compounding.

However, many peptide therapies used in horses fall into a category known as “compounded” drugs. This is where the regulatory framework becomes more complex.

What is Compounded Peptide Therapy?

Animal drug compounding is the process of combining, mixing, or altering ingredients to create a medication tailored to the needs of an individual animal or a small group of animals. This is often necessary when there is no FDA-approved drug available in the required dosage form or strength, or when a horse is allergic to an ingredient in an approved product.

Veterinarians may prescribe compounded peptides for a variety of reasons, including:

Musculoskeletal injuries: To promote the healing of tendons, ligaments, and muscles.

Wound care: To accelerate tissue regeneration and reduce scarring.

Metabolic conditions: To help manage conditions like Equine Metabolic Syndrome (EMS).

Performance recovery: To aid in post-exercise recovery and reduce muscle soreness.

While compounding can provide essential treatment options, it's important to recognize that compounded drugs are not FDA-approved. This means they have not undergone the same level of scrutiny for safety, effectiveness, and quality as approved drugs. The FDA has expressed concerns about the risks associated with some compounded drugs, including the potential for contamination, incorrect dosages, and adverse reactions. PMID: 35428927

---

The specialists at TeleGenix can help you understand the complexities of peptide therapy and whether it is right for your horse.

---

Common Peptides in Equine Therapy

A growing number of peptides are being used in equine medicine. While research is ongoing for many of these compounds, some have shown promising results in preliminary studies. For those interested in the specifics of peptide compounds, the /compounds page offers more detail.

| Peptide | Potential Application in Horses | Regulatory Status |

| :--- | :--- | :--- |

| BPC-157 | Tendon, ligament, and muscle healing; gut health | Not FDA-approved; available as a compounded drug |

| TB-500 (Thymosin Beta-4) | Tissue repair, reduced inflammation, improved flexibility | Not FDA-approved; available as a compounded drug |

| CJC-1295 / Ipamorelin | Growth hormone stimulation, muscle growth, fat loss | Not FDA-approved; available as a compounded drug |

| GHK-Cu | Wound healing, anti-inflammatory, antioxidant | Not FDA-approved; available as a compounded drug |

It is crucial to note that the use of these peptides is often considered “off-label,” meaning they are being used for a purpose other than what they were originally approved for (if they were approved at all). Horse owners should always work with a qualified veterinarian who can assess the specific needs of their animal and determine the most appropriate course of treatment. A good starting point for research is the /library.

A Closer Look at BPC-157 and TB-500

BPC-157, a peptide chain derived from a protein found in the stomach, has gained significant attention for its regenerative capabilities. Studies in other species have shown that it can accelerate the healing of a variety of tissues, including tendons, ligaments, muscles, and even the gastrointestinal tract. In horses, it is often used to treat soft tissue injuries and to support gut health. While the exact mechanisms are still being investigated, it is believed that BPC-157 promotes the formation of new blood vessels (angiogenesis) and modulates inflammation.

TB-500, or Thymosin Beta-4, is another peptide that plays a crucial role in tissue repair. It is a naturally occurring protein that is found in high concentrations in platelets and other cells involved in the healing process. TB-500 has been shown to promote cell migration, reduce inflammation, and protect cells from damage. In horses, it is often used to treat muscle injuries, reduce post-exercise soreness, and improve overall recovery.

Navigating the FDA's Guidance on Compounding

The FDA has issued guidance for the industry, known as Guidance for Industry (GFI) #256, which outlines its policy on compounding animal drugs from bulk drug substances. This guidance is intended to ensure that compounded drugs are only used when necessary and that they are prepared in a way that minimizes risks to animal and public health. You can learn more about different conditions on our /conditions page.

Key takeaways from the FDA's guidance include:

Patient-specific prescriptions: Compounded drugs should generally be prepared for a specific patient based on a veterinarian's prescription.

Office stock: In some cases, a veterinarian may be able to obtain limited quantities of compounded drugs to keep in their office for immediate use.

Bulk drug substances: The FDA maintains lists of bulk drug substances that can and cannot be used in compounding. These lists are based on a review of the available safety and effectiveness data.

Targeted action: Peptides can be designed to target specific cells and tissues, which may lead to more effective treatment with fewer side effects.

Accelerated healing: Many peptides have been shown to promote tissue regeneration and accelerate the healing of injuries.

Reduced inflammation: Some peptides have potent anti-inflammatory effects, which can help to reduce pain and swelling.

Improved performance and recovery: By supporting muscle growth, reducing soreness, and promoting overall well-being, peptide therapy may help to enhance athletic performance and speed up recovery times.

Lack of regulation: Because most peptides are not FDA-approved, there is less oversight of their manufacturing and quality control. This can lead to products that are contaminated, contain the wrong ingredients, or are not the correct strength.

Adverse reactions: As with any drug, there is a risk of adverse reactions to peptide therapy. These can range from mild skin irritation at the injection site to more serious systemic effects.

Unknown long-term effects: The long-term effects of many peptides are still unknown. More research is needed to determine the safety of these compounds over time.

The Future of Equine Peptide Therapy and FDA Regulation

The field of peptide therapy is rapidly advancing, and the regulatory landscape is likely to continue to evolve. As more research becomes available on the safety and effectiveness of different peptides, we may see some of these compounds go through the formal FDA approval process. PMID: 32998242

In the meantime, it is essential for horse owners to be informed consumers. When considering peptide therapy for your horse, be sure to:

Consult with a trusted veterinarian: A veterinarian can help you weigh the potential benefits and risks of peptide therapy and determine if it is the right choice for your horse. For those looking for a vet, the /trt-near-me page can be a helpful tool.

Use a reputable compounding pharmacy: If you and your veterinarian decide to use a compounded peptide, make sure it is prepared by a pharmacy that is licensed and follows all applicable state and federal regulations.

Monitor your horse closely: Pay close attention to your horse's response to the treatment and report any adverse effects to your veterinarian immediately.

Disclaimer: This article is for educational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before starting any treatment.*

---

Related Articles